Compound Evidence File
#EC-2026-0166
Arimidex (Anastrozole)
Filed under Oral Tablets. The bureau holds 55 laboratory returns for this compound from 25 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
25 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 9.1 | 9.1 | 9.1 | 8 Jul 2025 | 8 Jul 2025 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 9.1 | 9.1 | 9.1 | 24 Apr 2025 | 24 Apr 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.9 | 6.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.4 | 6.7 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 8.3 | 7.2 | 9.4 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 7.9 | 6.6 | 9.1 | 24 May 2026 | 24 May 2026 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 1 | 7.9 | 7.9 | 7.9 | 21 May 2025 | 21 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 7.7 | 6.8 | 8.7 | 23 May 2026 | 23 May 2026 |
| NexaphCASE #VI-2026-0944 | X | 3 | 7.7 | 6.0 | 9.1 | 27 Feb 2025 | 21 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 7.7 | 7.7 | 7.7 | 13 Jun 2025 | 13 Jun 2025 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 1 | 7.6 | 7.6 | 7.6 | 20 Jun 2025 | 20 Jun 2025 |
| Skye PeptidesCASE #VI-2026-0451 | X | 2 | 7.5 | 6.3 | 8.7 | 8 Jul 2025 | 23 May 2026 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 7.1 | 7.1 | 7.1 | 2 Jul 2025 | 2 Jul 2025 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 7.1 | 7.1 | 7.1 | 9 Jun 2025 | 9 Jun 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 7.0 | 7.0 | 7.0 | 14 Jan 2025 | 14 Jan 2025 |
| NextechLabsCASE #VI-2026-0285 | X | 2 | 6.7 | 6.2 | 7.1 | 6 May 2025 | 24 May 2026 |
| Verified PeptidesCASE #VI-2026-0407 | X | 1 | 6.7 | 6.7 | 6.7 | 24 Apr 2025 | 24 Apr 2025 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 6.5 | 6.5 | 6.5 | 6 May 2025 | 6 May 2025 |
| Mai PeptideCASE #VI-2026-0769 | X | 1 | 5.5 | 5.5 | 5.5 | 9 Jun 2025 | 9 Jun 2025 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 4.9 | 4.9 | 4.9 | 17 Dec 2024 | 17 Dec 2024 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 3.1 | 3.1 | 3.1 | 28 Mar 2025 | 28 Mar 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 1.6 | 1.6 | 1.6 | 24 Apr 2025 | 24 Apr 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 1.3 | 1.3 | 1.3 | 2 Jul 2025 | 2 Jul 2025 |
Open any subject to view the batch-level evidence for Arimidex (Anastrozole) alone.